The Work We Fund

Funded projects
1,250+
Men's Health Partners
20
Countries
20
We work closely with our global men's health partners to ensure collaboration, transparency and accountability for every project we fund. We monitor this through report cards which detail what we seek to achieve, key measures and the impact.
Prostate Cancer
"Together with the brightest minds in research, we aim to achieve significant breakthroughs in the hope of beating prostate cancer. Our disruptive funding approach identifies revolutionary ways to accelerate health outcomes by creating strong, global collaborative teams." Dr. Colleen Nelson, Global Scientific Chair.
Men's Health
"One Mo can help change the face of men’s health through the powerful conversations created globally during Movember. Men have the chance to confidently discuss men’s health with people around them, resulting in men taking action early, helping change and save lives." Paul Villanti, Executive Director, Programs
Mental health and suicide prevention
“The number of men taking their own lives around the world is one of the biggest challenges of our time. Movember is working to ensure all men and boys look after their mental health and are comfortable to seek help when they’re struggling.”
Brendan Maher, Global Director, Mental Health and Suicide Prevention.
Testicular Cancer
“Despite being the 2nd most common cancer in young men, testicular cancer is often a forgotten cancer due to early detection and treatment. Our projects look at underinvested areas such as improving access to healthcare services and treatment options for relapse” Paul Villanti, Executive Director, Programs.

Movember Clinical Trial Awards

Movember Funding to Date

AUD 2,475,656

What we seek to achieve

The Movember Foundation Clinical Trial Award supports clinical trials initiated in Australia that have the capacity to transform the clinical management of men with prostate cancer within the course of the trial and/or immediately post completion of the trial.

Country
Australia
Co-funded
Distinguished Gentleman's Ride AUD 92,372
Implemented by
Movember Foundation and Prostate Cancer Foundation of Australia
Project start date
January 2015
Project Status
In Progress

About the project

Applications for Movember Foundation Clinical Trial Awards are open to all eligible Australian institutions and must focus on one or more of the following : 1. Better tests for the diagnosis of prostate cancer; 2. Biomarkers for monitoring of treatment: 3. Better imaging; 4. New and improved therapies; 5. Survivorship and palliative care.

This funding scheme recognises the growing capacity for conducting clinical trials in Australia and aims to assist in further building this capacity in collaboration with leading experts globally. These clinical trials will:
•    Provide immediate benefit to men living with prostate cancer (i.e. men with prostate cancer would participate in these clinical trials and reap the benefit of treatments that are in the pipeline).
•    Increase participation in international clinical trials for which Australian men with prostate cancer would not otherwise be eligible.

It is anticipated that the award will achieve its aims via:
•    harnessing existing strengths;
•    seizing present and future opportunities;
•    fostering a collaborative approach between researchers conducting clinical trials in Australia and internationally;
•    enabling the Australian prostate clinical research community to contribute to a near term impact on the clinical        management of prostate cancer.

In June 2015, PCFA and Movember Foundation appointed an international expert review panel comprising the basic science and clinical expertise needed to assess all submitted applications. Two clinical trials were funded: 

Professor Howard Gurney - Macquarie University, Sydney, NSW, is working on aPhase II randomised controlled trial of high-dose Vitamin D in localised prostate cancer cases with intermediate risk of progression (ProsD). This intervention has potential to reduce anxiety in men with low- to intermediate-risk prostate cancer.

Associate Professor Michael Hofman - Peter MacCallum Cancer Centre/ The University of Melbourne, Melbourne, VIC, is conducting a prospective multicentre study of the impact of Ga-68 PSMA-PET/CT imaging in the management of prostate cancer (proPSMA study). If it can be shown that PSMA-PET/CT has superior diagnostic performance, it should be used as a first-line test for staging prior to surgery or radiotherapy and will result in significant changes to patient management.

Prostate Cancer Research Alliance

The Program will fund research that leverages Australia's existing strengths in prostate cancer biomedical research to deliver outcomes that can be translated into clinical practice within the next 5 to 7 years.

Find out more
Australia
AUD 6,150,000
USA - Mass market, multi-platform public media documentary series & campaign

This project uses a mass market, multi dimensional campaigns to shift populations understanding, attitudes and intentions and ultimately improve health outcomes on a large scale. Focusing on Youth Mental Health we will be working in partnership with PBS to deliver a documentary series supported with educational, digital and in person elements delivered across the USA.

Find out more
United States
USD 2,400,000
Men in Mind

The vision of this project is to be the ‘go to’ training resource for clinicians across the world seeking to (a) understand the needs and preferences of men, (b) gain training to better understand and respond to men's distress, (c) increase their confidence and competence in engaging with male client's, and (d) provide a gate way to Movember’s other tools, resources to stay mentally healthy and well.

Find out more
Australia
Global Funding AUD 1,521,959
Ironman Registry

IRONMAN is an international, population-based registry of 5,000 men with advanced prostate cancer across ten countries. It seeks to understand clinical outcomes associated with management of advanced prostate cancer and understand the biological and clinical diversity of the disease.

Find out more
South Africa
Global Funding AUD 18,228,055
Ironman Registry

IRONMAN is an international, population-based registry of 5,000 men with advanced prostate cancer across ten countries. It seeks to understand clinical outcomes associated with management of advanced prostate cancer and understand the biological and clinical diversity of the disease.

Find out more
Spain
Global Funding AUD 18,228,055
Ironman Registry

IRONMAN is an international, population-based registry of 5,000 men with advanced prostate cancer across ten countries. It seeks to understand clinical outcomes associated with management of advanced prostate cancer and understand the biological and clinical diversity of the disease.

Find out more
Ireland
Global Funding AUD 18,228,055
Ironman Registry

IRONMAN is an international, population-based registry of 5,000 men with advanced prostate cancer across ten countries. It seeks to understand clinical outcomes associated with management of advanced prostate cancer and understand the biological and clinical diversity of the disease.

Find out more
Switzerland
Global Funding AUD 18,228,055
Ironman Registry

IRONMAN is an international, population-based registry of 5,000 men with advanced prostate cancer across ten countries. It seeks to understand clinical outcomes associated with management of advanced prostate cancer and understand the biological and clinical diversity of the disease.

Find out more
Sweden
Global Funding AUD 18,228,055
Ironman Registry

IRONMAN is an international, population-based registry of 5,000 men with advanced prostate cancer across ten countries. It seeks to understand clinical outcomes associated with management of advanced prostate cancer and understand the biological and clinical diversity of the disease.

Find out more
United States
Global Funding AUD 18,228,055
Ironman Registry

IRONMAN is an international, population-based registry of 5,000 men with advanced prostate cancer across ten countries. It seeks to understand clinical outcomes associated with management of advanced prostate cancer and understand the biological and clinical diversity of the disease.

Find out more
United Kingdom
Global Funding AUD 18,228,055
Ironman Registry

IRONMAN is an international, population-based registry of 5,000 men with advanced prostate cancer across ten countries. It seeks to understand clinical outcomes associated with management of advanced prostate cancer and understand the biological and clinical diversity of the disease.

Find out more
Canada
Global Funding AUD 18,228,055
Ironman Registry

IRONMAN is an international, population-based registry of 5,000 men with advanced prostate cancer across ten countries. It seeks to understand clinical outcomes associated with management of advanced prostate cancer and understand the biological and clinical diversity of the disease.

Find out more
Australia
Global Funding AUD 18,228,055
Movember – Distinguished Gentleman’s Ride Clinician Scientist Award - 2017

Clinician Scientist Awards aim to support outstanding, clinically qualified professionals who have gained a PhD in health research, to combine their clinical career with a research career and establish themselves as independent researchers in the field of prostate cancer.

Find out more
Australia
-
TrueNTH Global Registry

Operating across 13 Movember countries, the TrueNTH Global Registry is an international project that aims to significantly improve the physical and mental health of men with prostate cancer.

Find out more
Australia
Global Funding AUD 18,178,871
Canadian Men's Health & Wellbeing Innovation Challenge

To support the implementation of outside the box proof of concept ideas that disrupt long held assumptions/myths about men and their health which will encourage doing things differently and ultimately lead to improved health outcomes.

Find out more
Canada
CAD 1,923,149
Prostate Cancer Outcomes - Registry Australia and New Zealand

To establish a bi-national population based registry of men who have been diagnosed with prostate cancer in order to build evidence that supports risk adjusted feedback reports for hospitals and clinicians and helps deliver improved quality of treatment and care to patients.

Find out more
Australia
AUD 22,397,860
>
Page 1 of 29